Sirolimus coated stent
ABLUMINUS DES+ was developed from the proprietary ENVISOLUTION technology to address unmet clinical needs in patients with diabetes mellitus and acute myocardial infarction with coronary artery disease.
Facilitate mono directional drug release and less systemic exposure of drug leading to faster re-endothelistation
Coating on the stent and exposed parts of the balloon facilitate homogenous drug delivery which address diffused proliferative disease and focal restenosis
The additional 0.5mm coating on the edge of the balloon which addresses the edge restenosis
The formation of circular film with biodegradable polymer facilitate maximum drug delivery in blood wet conditions